Joseph Delehanty
Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Heart Failure | 9 | 1993 | 106 |
Why?
|
Norepinephrine | 7 | 1992 | 68 |
Why?
|
Ventricular Dysfunction, Left | 2 | 1999 | 35 |
Why?
|
Forearm | 2 | 1999 | 25 |
Why?
|
Mitral Valve Prolapse | 1 | 2000 | 7 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2000 | 5 |
Why?
|
Hemodynamics | 5 | 1992 | 131 |
Why?
|
Dobutamine | 1 | 1999 | 19 |
Why?
|
Adrenergic beta-Agonists | 1 | 1999 | 39 |
Why?
|
Vasodilation | 1 | 1999 | 30 |
Why?
|
Ischemia | 1 | 1999 | 65 |
Why?
|
Myocardial Ischemia | 1 | 1999 | 62 |
Why?
|
Blood Circulation | 2 | 1995 | 26 |
Why?
|
Cardiac Pacing, Artificial | 5 | 1993 | 27 |
Why?
|
Hyperemia | 2 | 1999 | 18 |
Why?
|
Muscle, Skeletal | 3 | 2002 | 114 |
Why?
|
Extracellular Space | 1 | 1994 | 58 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1994 | 35 |
Why?
|
Down-Regulation | 2 | 1994 | 150 |
Why?
|
Aging | 3 | 2002 | 275 |
Why?
|
Myocardium | 4 | 1993 | 119 |
Why?
|
Coronary Angiography | 3 | 1996 | 49 |
Why?
|
Dichloroacetate | 1 | 1992 | 5 |
Why?
|
Physical Exertion | 1 | 1992 | 46 |
Why?
|
Dogs | 8 | 1992 | 159 |
Why?
|
Hypothermia, Induced | 1 | 2010 | 16 |
Why?
|
Heart Arrest | 1 | 2010 | 37 |
Why?
|
Coronary Disease | 3 | 1996 | 94 |
Why?
|
Particulate Matter | 1 | 2008 | 22 |
Why?
|
Inhalation Exposure | 1 | 2008 | 22 |
Why?
|
Carbon | 1 | 2008 | 30 |
Why?
|
Oxygen Consumption | 3 | 1992 | 86 |
Why?
|
Air Pollutants | 1 | 2008 | 42 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 2 | 1994 | 22 |
Why?
|
Baroreflex | 2 | 1994 | 9 |
Why?
|
Exercise | 3 | 1995 | 82 |
Why?
|
Gene Expression Profiling | 2 | 2003 | 138 |
Why?
|
Humans | 13 | 1995 | 1856 |
Why?
|
Middle Aged | 6 | 1996 | 1161 |
Why?
|
DNA, Mitochondrial | 1 | 2002 | 32 |
Why?
|
Hormone Replacement Therapy | 1 | 2000 | 12 |
Why?
|
Patient Education as Topic | 1 | 2002 | 128 |
Why?
|
Aged | 6 | 1999 | 988 |
Why?
|
Attitude to Health | 1 | 2002 | 106 |
Why?
|
Angina, Unstable | 1 | 1999 | 20 |
Why?
|
Vascular Resistance | 1 | 1999 | 51 |
Why?
|
Peripheral Vascular Diseases | 1 | 1999 | 26 |
Why?
|
Animals | 9 | 1992 | 1031 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1999 | 48 |
Why?
|
Female | 8 | 1996 | 1643 |
Why?
|
Regional Blood Flow | 1 | 1999 | 105 |
Why?
|
Calcium-Transporting ATPases | 1 | 1998 | 17 |
Why?
|
Sarcoplasmic Reticulum | 1 | 1998 | 21 |
Why?
|
Wounds, Stab | 1 | 1996 | 6 |
Why?
|
Cardiac Tamponade | 1 | 1996 | 14 |
Why?
|
Ventricular Function, Left | 2 | 1993 | 41 |
Why?
|
Thoracic Injuries | 1 | 1996 | 22 |
Why?
|
Isoenzymes | 2 | 1994 | 144 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1998 | 104 |
Why?
|
Adult | 7 | 1996 | 1317 |
Why?
|
Cardiac Output | 2 | 1992 | 48 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 1996 | 29 |
Why?
|
Epinephrine | 2 | 1992 | 53 |
Why?
|
Nitroprusside | 1 | 1994 | 24 |
Why?
|
Risk Assessment | 1 | 1999 | 324 |
Why?
|
Male | 7 | 1992 | 1553 |
Why?
|
Electrocardiography | 1 | 1999 | 132 |
Why?
|
Naloxone | 1 | 1994 | 22 |
Why?
|
Myosin Heavy Chains | 2 | 2003 | 14 |
Why?
|
Models, Cardiovascular | 1 | 1994 | 40 |
Why?
|
Sympathetic Nervous System | 1 | 1993 | 43 |
Why?
|
Pyruvates | 1 | 1992 | 22 |
Why?
|
Pyruvic Acid | 1 | 1992 | 12 |
Why?
|
Heart Rate | 1 | 1994 | 138 |
Why?
|
Heart | 1 | 1993 | 88 |
Why?
|
Lactates | 1 | 1992 | 49 |
Why?
|
Lactic Acid | 1 | 1992 | 44 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2003 | 135 |
Why?
|
Myocardial Infarction | 1 | 1996 | 129 |
Why?
|
Adaptation, Physiological | 1 | 1992 | 74 |
Why?
|
Algorithms | 1 | 1994 | 226 |
Why?
|
Ventricular Fibrillation | 1 | 2010 | 24 |
Why?
|
RNA, Messenger | 3 | 1998 | 394 |
Why?
|
Age Factors | 1 | 2010 | 480 |
Why?
|
Prognosis | 1 | 2010 | 388 |
Why?
|
Disease Models, Animal | 3 | 1994 | 349 |
Why?
|
Aged, 80 and over | 2 | 2000 | 599 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 24 |
Why?
|
Muscular Atrophy | 1 | 2003 | 14 |
Why?
|
Energy Metabolism | 1 | 2004 | 80 |
Why?
|
Tumor Suppressor Proteins | 1 | 2004 | 51 |
Why?
|
Histone Deacetylases | 1 | 2004 | 30 |
Why?
|
Physical Fitness | 1 | 2002 | 18 |
Why?
|
Genes | 1 | 2003 | 82 |
Why?
|
Osmolar Concentration | 1 | 2002 | 91 |
Why?
|
Treatment Outcome | 1 | 2010 | 661 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 71 |
Why?
|
Cyclooxygenase 2 | 1 | 2002 | 77 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 66 |
Why?
|
Time Factors | 1 | 2008 | 896 |
Why?
|
Attitude | 1 | 2000 | 54 |
Why?
|
Data Collection | 1 | 2000 | 137 |
Why?
|
Calsequestrin | 1 | 1998 | 3 |
Why?
|
Adolescent | 1 | 2008 | 891 |
Why?
|
Membrane Proteins | 1 | 2002 | 233 |
Why?
|
Infusions, Parenteral | 1 | 1998 | 38 |
Why?
|
Microsomes | 1 | 1998 | 27 |
Why?
|
Calcium-Binding Proteins | 1 | 1998 | 49 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 277 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 1998 | 21 |
Why?
|
Hemothorax | 1 | 1996 | 10 |
Why?
|
Pericardial Effusion | 1 | 1996 | 18 |
Why?
|
Coronary Vessel Anomalies | 1 | 1996 | 12 |
Why?
|
Punctures | 1 | 1996 | 22 |
Why?
|
Streptokinase | 1 | 1996 | 18 |
Why?
|
Thrombolytic Therapy | 1 | 1996 | 42 |
Why?
|
Equipment Design | 1 | 1996 | 132 |
Why?
|
Pressoreceptors | 1 | 1994 | 10 |
Why?
|
Risk Factors | 1 | 2002 | 555 |
Why?
|
Phenylephrine | 1 | 1994 | 25 |
Why?
|
Ventricular Function | 1 | 1994 | 23 |
Why?
|
Infusions, Intravenous | 1 | 1994 | 87 |
Why?
|
Random Allocation | 1 | 1994 | 160 |
Why?
|
Ouabain | 1 | 1994 | 18 |
Why?
|
beta-Endorphin | 1 | 1994 | 12 |
Why?
|
Recurrence | 1 | 1996 | 261 |
Why?
|
Nerve Endings | 1 | 1993 | 12 |
Why?
|
Ventricular Function, Right | 1 | 1993 | 15 |
Why?
|
Myocardial Contraction | 1 | 1994 | 52 |
Why?
|
Receptors, Opioid | 1 | 1994 | 16 |
Why?
|
Heart Ventricles | 1 | 1994 | 86 |
Why?
|
Regression Analysis | 1 | 1994 | 256 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 1993 | 30 |
Why?
|
Blood Pressure | 1 | 1994 | 205 |
Why?
|
Blotting, Western | 1 | 1994 | 275 |
Why?
|
Binding Sites | 1 | 1994 | 213 |
Why?
|
